Christy J. Oliger
Sits on 5 boards. Overboarded · 5 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 5
- Current seats
- 5
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 5 boards, counting each seat separately. Longest: Replimune Group Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Karyopharm Therapeutics Inc. May 21, 202692.7%
-
Replimune Group Inc. September 2, 202592.4%
-
Karyopharm Therapeutics Inc. May 24, 202386.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 21, 2026 | Karyopharm Therapeutics Inc. | Grant or award | +15,508 | — | — |
Questions about Christy J. Oliger
What boards is Christy J. Oliger on?
Christy J. Oliger sits on the boards of Bicara Therapeutics Inc., Karyopharm Therapeutics Inc., Replimune Group Inc., Vera Therapeutics Inc. and Zenas BioPharma Inc.
How long has Christy J. Oliger served on boards?
Our records show at least 10 years of board service across 5 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.